| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
44,215,000 |
| Market
Cap: |
4.11(M) |
| Last
Volume: |
17,424 |
Avg
Vol: |
59,181 |
| 52
Week Range: |
$0.06 - $0.2089 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Enzon Pharmaceuticals is engaged in existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize Co.'s proprietary technology. Co. has a marketing agreement relating to the drug Vicineum.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
99,550 |
99,550 |
| Total Buy Value |
$0 |
$0 |
$13,910 |
$13,910 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Micati Victor P |
Director |
– • – |
2008-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,105 |
21,130 |
|
- |
|
| Renfro Phillip M |
Director |
– • – |
2008-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,172 |
14,868 |
|
- |
|
| Classon Rolf A |
Director |
– • – |
2008-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,172 |
29,720 |
|
- |
|
| Ando Goran |
Director |
– • – |
2008-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,172 |
20,025 |
|
- |
|
| Lebuhn Robert |
Director |
– • – |
2008-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,172 |
100,919 |
|
- |
|
| Micati Victor P |
Director |
– • – |
2008-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,172 |
20,025 |
|
- |
|
| Salisbury Robert C |
Director |
– • – |
2008-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,105 |
25,161 |
|
- |
|
| Renfro Phillip M |
Director |
– • – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
11,696 |
|
- |
|
| Renfro Phillip M |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,417 |
10,441 |
|
- |
|
| Classon Rolf A |
Director |
– • – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
26,548 |
|
- |
|
| Classon Rolf A |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,417 |
25,293 |
|
- |
|
| Ando Goran |
Director |
– • – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
16,853 |
|
- |
|
| Ando Goran |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,417 |
15,598 |
|
- |
|
| Lebuhn Robert |
Director |
– • – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
97,747 |
|
- |
|
| Lebuhn Robert |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,417 |
96,492 |
|
- |
|
| Micati Victor P |
Director |
– • – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
16,853 |
|
- |
|
| Micati Victor P |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,417 |
15,598 |
|
- |
|
| Salisbury Robert C |
Director |
– • – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,427 |
24,056 |
|
- |
|
| Salisbury Robert C |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,417 |
19,629 |
|
- |
|
| Geltosky John |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,417 |
18,760 |
|
- |
|
| Geltosky John |
Director |
– • – |
2008-05-22 |
4 |
A |
$8.99 |
$75,004 |
D/D |
8,343 |
8,343 |
|
- |
|
| Delcampo Ralph |
EVP - Technical Operations |
• – – |
2008-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
121,156 |
|
- |
|
| Tooman Craig A |
Exec VP Finance, CFO |
• – – |
2008-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
116,122 |
|
- |
|
| Renfro Phillip M |
Director |
– • – |
2008-05-12 |
4 |
S |
$9.49 |
$142,281 |
D/D |
(15,000) |
24 |
|
- |
|
| Renfro Phillip M |
Director |
– • – |
2008-05-12 |
4 |
OE |
$7.40 |
$111,000 |
D/D |
15,000 |
15,024 |
|
- |
|
394 Records found
|
|
Page 12 of 16 |
|
|
